• Subject: RE: Client Access Sessions taking forever to bring up Signon Scre en
  • From: Joe Giusto <JGiusto@xxxxxxxxxxxx>
  • Date: Tue, 9 Jan 2001 14:38:43 -0500

Thank you for clarifying that for me.  I have check one of the PC's that had
the problem this morning and it did have the IP address and name of our 400.


-----Original Message-----
From:   Draper, Dale [SMTP:dale.draper@seu.sega.com]
Sent:   Tuesday, January 09, 2001 2:04 PM
To:     'MIDRANGE-L@midrange.com'
Subject:        RE: Client Access Sessions taking forever to bring up Signon
Scre en

I think he did mention making sure that your AS400 IP is on the PC's hosts
file. If you do not have a *hosts* file, edit the hosts.sam, adding your
AS400's name and IP and then save as *hosts*. 
I beleive that is what he was suggesting anyway.



> -----Original Message-----
> From: Joe Giusto [SMTP:JGiusto@patuxent.com]
> Sent: Tuesday, January 09, 2001 10:01 AM
> To:   'MIDRANGE-L@midrange.com'
> Subject:      RE: Client Access Sessions taking forever to bring up Signon
> Scre en
> 
> 27.3601%. (the highest on any one drive on the WRKDSKSTS screen is 72.2%).
> 
> It has been suggested that it has something to do with reverse DNS Lookup
> and that I should tell the 400 what the addresses are.  The problem with
> that is that they are dynamically assigned by the NT server and we are
> talking at least 50 users.  Unless there is a way to generically tell the
> 400 about a range of addresses.

+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com
+---

This thread ...


Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].